DUBLIN, June 7, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leader in women's healthcare and the maker of Lo Loestrin^® Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), today announced the launch of  'BC Trivia' featuring actress and new ambassador Shay Mitchell – a fun and engaging trivia quiz designed to educate young women about contraceptive options in a familiar way for its bold educational platform, Know Your Birth Control^®.

DUBLIN, June 5, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today issued the following statement in response to a public shareholder letter: Allergan's board of directors and management welcome input from all our shareholders, and take into account their views. Our board and management are committed to creating a world class biopharmaceutical and aesthetics business and driving shareholder returns. The conclusion of our recently completed strategic review is to create a more focused Allergan that concentrates on four therapeutic areas where we have leadership positions and depth and breadth of our products and pipeline, and to pursue a disciplined capital allocation strategy to generate value for shareholders.

DUBLIN, June 5, 2018 /PRNewswire/ -- Allergan plc (NYSE:AGN) today announced that, in honor of Alzheimer's & Brain Awareness Month, it is teaming up with notable celebrities Scott Conant, Sean Hayes, Helen Hunt, Soleil Moon Frye, Molly Sims and Trista Sutter to shine light on what can be a very challenging time for Alzheimer's caregivers, as part of the company's 'Hold on to Hope' initiative.

DUBLIN, May 30, 2018 /PRNewswire/ -- According to the American Society for Aesthetic Plastic Surgery, Hispanics are a key customer group for in-office medical aesthetic procedures, growing 23.5 percent from 2010 to 2017². This statistic served as a jumping-off point for a conversation about aesthetic treatments, including the CoolSculpting^® treatment, during a May 19 event hosted by Allergan plc (NYSE: AGN) and the #WeAllGrow Latina network. The panel discussion featured Dr. Vivian Bucay, a board-certified dermatologist; Gia Fey, Curveygirls Fitness trainer and creator of Body by Gia; and Ana Flores, Founder and Chief Executive Officer of #WeAllGrow Latina Network, an organization dedicated to leveraging social influence to grow a community of Latinas through online conversation. The CoolSculpting^® treatment is FDA-cleared and clinically proven to eliminate stubborn fat using a patented cooling technology.

DUBLIN, May 29, 2018 /PRNewswire/ -- Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules.

DUBLIN, May 16, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the Bernstein 34^th Annual Strategic Decisions Conference in New York, NY. The presentation will begin at 10:00 a.m. Eastern Time on Wednesday, May 30, 2018.

DUBLIN, May 7, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Commercial Officer William Meury will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas, Nevada. The presentation will begin at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) on Thursday, May 17, 2018.

DUBLIN, May 3, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that John Davidson has been elected to its Board of Directors. Mr. Davidson and the other directors standing for re-election to Allergan's Board were elected at Allergan's Annual General Meeting of Shareholders on May 2, 2018. With the addition of Mr. Davidson, and the previously announced retirement of directors James Bloem and Ronald Taylor, the Allergan Board now has 12 members.

DUBLIN, May 3, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.72 per ordinary share for the second quarter of 2018. The dividend will be paid on June 15, 2018 to shareholders of record at the close of business on May 18, 2018.

DUBLIN, May 2, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that they will showcase new data during the upcoming American Psychiatric Association (APA) Annual Meeting in New York City from May 5 to May 9, 2018. The company will present eight posters highlighting new data and clinical research across schizophrenia, bipolar I disorder, and major depressive disorder (MDD) therapeutic areas as part of the company's efforts towards advancing scientific discovery for underserved patient populations. The APA poster presentations will feature data for cariprazine, rapastinel and onabotulinumtoxinA.